{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:42:16Z","timestamp":1792561336374,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Youth Cultivation Program for the National Natural Science Foundation of China at Nanjing Drum Tower Hospital","award":["2025-JCYJ-QP-022"],"award-info":[{"award-number":["2025-JCYJ-QP-022"]}]},{"name":"Key Medical Science and Technology Development Project of Nanjing","award":["ZKX24011"],"award-info":[{"award-number":["ZKX24011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"DOI":"10.1007\/s10096-026-05704-0","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:11:19Z","timestamp":1792559479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Initial empiric carbapenem versus non-carbapenem \u03b2-lactam\/\u03b2-lactamase inhibitor therapy in sepsis across simplified SENECA phenotypes: a retrospective study of two independent cohorts"],"prefix":"10.1007","author":[{"given":"Haoyang","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuohan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuchao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"issue":"8","key":"5704_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW et al (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315(8):801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"issue":"4","key":"5704_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/CCM.0000000000007075","volume":"54","author":"HC Prescott","year":"2026","unstructured":"Prescott HC, Antonelli M, Alhazzani W et al (2026) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026. Crit Care Med 54(4):725\u2013812. https:\/\/doi.org\/10.1097\/CCM.0000000000007075","journal-title":"Crit Care Med"},{"issue":"4","key":"5704_CR3","doi-asserted-by":"publisher","first-page":"e202899","DOI":"10.1001\/jamanetworkopen.2020.2899","volume":"3","author":"C Rhee","year":"2020","unstructured":"Rhee C, Kadri SS, Dekker JP et al (2020) Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open 3(4):e202899. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.2899","journal-title":"JAMA Netw Open"},{"issue":"10","key":"5704_CR4","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","volume":"62","author":"TF Barlam","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM et al (2016) Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 62(10):e51\u2013e77. https:\/\/doi.org\/10.1093\/cid\/ciw118","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5704_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/jac\/dku351","volume":"70","author":"S Shiber","year":"2015","unstructured":"Shiber S, Yahav D, Avni T, Leibovici L, Paul M (2015) \u03b2-Lactam\/\u03b2-lactamase inhibitors versus carbapenems for the treatment of sepsis: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 70(1):41\u201347. https:\/\/doi.org\/10.1093\/jac\/dku351","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"5704_CR6","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1097\/CCM.0000000000005932","volume":"51","author":"Y Umemura","year":"2023","unstructured":"Umemura Y, Yamakawa K, Tanaka Y, Yoshimura J, Ogura H, Fujimi S (2023) Efficacy of carbapenems compared with noncarbapenem broad-spectrum beta-lactam antibiotics as initial antibiotic therapy against sepsis: a nationwide observational study. Crit Care Med 51(9):1210\u20131221. https:\/\/doi.org\/10.1097\/CCM.0000000000005932","journal-title":"Crit Care Med"},{"issue":"7","key":"5704_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/jamainternmed.2024.0581","volume":"184","author":"R Chanderraj","year":"2024","unstructured":"Chanderraj R, Admon AJ, He Y et al (2024) Mortality of patients with sepsis administered piperacillin-tazobactam vs cefepime. JAMA Intern Med 184(7):769\u2013777. https:\/\/doi.org\/10.1001\/jamainternmed.2024.0581","journal-title":"JAMA Intern Med"},{"issue":"9","key":"5704_CR8","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1093\/jac\/dkaf254","volume":"80","author":"Y Lee","year":"2025","unstructured":"Lee Y, Seong J, Lee JA et al (2025) Comparing the mortality of patients with sepsis using empirical piperacillin\/tazobactam and cefepime: analysis of the MIMIC-IV database. J Antimicrob Chemother 80(9):2487\u20132495. https:\/\/doi.org\/10.1093\/jac\/dkaf254","journal-title":"J Antimicrob Chemother"},{"issue":"20","key":"5704_CR9","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S et al (2019) Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA 321(20):2003\u20132017. https:\/\/doi.org\/10.1001\/jama.2019.5791","journal-title":"JAMA"},{"issue":"4","key":"5704_CR10","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s00134-025-07873-6","volume":"51","author":"DB Antcliffe","year":"2025","unstructured":"Antcliffe DB, Burrell A, Boyle AJ et al (2025) Sepsis subphenotypes, theragnostics and personalized sepsis care. Intensive Care Med 51(4):756\u2013768. https:\/\/doi.org\/10.1007\/s00134-025-07873-6","journal-title":"Intensive Care Med"},{"key":"5704_CR11","doi-asserted-by":"publisher","first-page":"103341","DOI":"10.1016\/j.eclinm.2025.103341","volume":"86","author":"X Lou","year":"2025","unstructured":"Lou X, Chen H, Shi N et al (2025) Treatment effects of Xuebijing injection in patients with sepsis by clinical phenotype: a post hoc analysis of the EXIT-SEP trial. EClinicalMedicine 86:103341. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103341","journal-title":"EClinicalMedicine"},{"issue":"9596","key":"5704_CR12","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, STROBE Initiative et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"issue":"1","key":"5704_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","volume":"10","author":"AEW Johnson","year":"2023","unstructured":"Johnson AEW, Bulgarelli L, Shen L et al (2023) MIMIC-IV, a freely accessible electronic health record dataset. Sci Data 10(1):1. https:\/\/doi.org\/10.1038\/s41597-022-01899-x","journal-title":"Sci Data"},{"key":"5704_CR14","doi-asserted-by":"publisher","DOI":"10.13026\/kpb9-mt58","author":"A Johnson","year":"2024","unstructured":"Johnson A, Bulgarelli L, Pollard T et al (2024) MIMIC-IV (version 3.1). PhysioNet. https:\/\/doi.org\/10.13026\/kpb9-mt58","journal-title":"PhysioNet"},{"issue":"5","key":"5704_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"issue":"11","key":"5704_CR16","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43(11):1130\u20131139. https:\/\/doi.org\/10.1097\/01.mlr.0000182534.19832.83","journal-title":"Med Care"},{"issue":"1","key":"5704_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2(1):1\u2013138. https:\/\/doi.org\/10.1038\/kisup.2012.1","journal-title":"Kidney Int Suppl"},{"key":"5704_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple Imputation for Nonresponse in Surveys","author":"DB Rubin","year":"1987","unstructured":"Rubin DB (1987) Multiple Imputation for Nonresponse in Surveys. Wiley, New York. https:\/\/doi.org\/10.1002\/9780470316696"},{"key":"5704_CR19","doi-asserted-by":"publisher","first-page":"b2393","DOI":"10.1136\/bmj.b2393","volume":"338","author":"JAC Sterne","year":"2009","unstructured":"Sterne JAC, White IR, Carlin JB et al (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 338:b2393. https:\/\/doi.org\/10.1136\/bmj.b2393","journal-title":"BMJ"},{"issue":"3","key":"5704_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res 46(3):399\u2013424. https:\/\/doi.org\/10.1080\/00273171.2011.568786","journal-title":"Multivar Behav Res"},{"issue":"28","key":"5704_CR21","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA (2015) Moving towards best practice when using inverse probability of treatment weighting using the propensity score to estimate causal treatment effects in observational studies. Stat Med 34(28):3661\u20133679. https:\/\/doi.org\/10.1002\/sim.6607","journal-title":"Stat Med"},{"issue":"1","key":"5704_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","volume":"80","author":"D Firth","year":"1993","unstructured":"Firth D (1993) Bias reduction of maximum likelihood estimates. Biometrika 80(1):27\u201338. https:\/\/doi.org\/10.1093\/biomet\/80.1.27","journal-title":"Biometrika"},{"key":"5704_CR23","doi-asserted-by":"publisher","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA (2024) Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections. . Clin Infect Dis ciae403 https:\/\/doi.org\/10.1093\/cid\/ciae403","DOI":"10.1093\/cid\/ciae403"},{"issue":"5","key":"5704_CR24","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M et al (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63(5):e61\u2013e111. https:\/\/doi.org\/10.1093\/cid\/ciw353","journal-title":"Clin Infect Dis"},{"key":"5704_CR25","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10096-019-03529-8","volume":"38","author":"M Andersson","year":"2019","unstructured":"Andersson M, \u00d6stholm-Balkhed \u00c5, Fredrikson M et al (2019) Delay of appropriate antibiotic treatment is associated with high mortality in patients with community-onset sepsis in a Swedish setting. Eur J Clin Microbiol Infect Dis 38:1223\u20131234. https:\/\/doi.org\/10.1007\/s10096-019-03529-8","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"5704_CR26","doi-asserted-by":"publisher","first-page":"O831","DOI":"10.1111\/1469-0691.12677","volume":"20","author":"Y Harada","year":"2014","unstructured":"Harada Y, Morinaga Y, Kaku N et al (2014) In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae. Clin Microbiol Infect 20(11):O831\u2013O839. https:\/\/doi.org\/10.1111\/1469-0691.12677","journal-title":"Clin Microbiol Infect"},{"key":"5704_CR27","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s10096-019-03769-8","volume":"39","author":"C Mabilat","year":"2020","unstructured":"Mabilat C, Gros MF, Nicolau D et al (2020) Diagnostic and medical needs for therapeutic drug monitoring of antibiotics. Eur J Clin Microbiol Infect Dis 39:791\u2013797. https:\/\/doi.org\/10.1007\/s10096-019-03769-8","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"5704_CR28","doi-asserted-by":"publisher","first-page":"2200910","DOI":"10.1183\/13993003.00910-2022","volume":"61","author":"R Chanderraj","year":"2023","unstructured":"Chanderraj R, Baker JM, Kay SG et al (2023) In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes. Eur Respir J 61(2):2200910. https:\/\/doi.org\/10.1183\/13993003.00910-2022","journal-title":"Eur Respir J"},{"issue":"4","key":"5704_CR29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/cid\/ciy936","volume":"69","author":"MM Pettigrew","year":"2019","unstructured":"Pettigrew MM, Gent JF, Kong Y et al (2019) Gastrointestinal microbiota disruption and risk of colonization with carbapenem-resistant Pseudomonas aeruginosa in intensive care unit patients. Clin Infect Dis 69(4):604\u2013613. https:\/\/doi.org\/10.1093\/cid\/ciy936","journal-title":"Clin Infect Dis"},{"issue":"5","key":"5704_CR30","doi-asserted-by":"publisher","first-page":"630","DOI":"10.7150\/ijms.30739","volume":"16","author":"C Teng","year":"2019","unstructured":"Teng C, Reveles KR, Obodozie-Ofoegbu OO, Frei CR (2019) Clostridium difficile infection risk with important antibiotic classes: an analysis of the FDA adverse event reporting system. Int J Med Sci 16(5):630\u2013635. https:\/\/doi.org\/10.7150\/ijms.30739","journal-title":"Int J Med Sci"},{"issue":"1","key":"5704_CR31","doi-asserted-by":"publisher","first-page":"e01730","DOI":"10.1128\/AAC.01730-17","volume":"62","author":"K van Loon","year":"2018","unstructured":"van Loon K, Voor in \u2018t Holt AF, Vos MC (2018) A systematic review and meta-analyses of the clinical epidemiology of carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother 62(1):e01730\u2013e01717. https:\/\/doi.org\/10.1128\/AAC.01730-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 7","key":"5704_CR32","doi-asserted-by":"publisher","first-page":"S521","DOI":"10.1093\/cid\/ciz824","volume":"69","author":"P Nordmann","year":"2019","unstructured":"Nordmann P, Poirel L (2019) Epidemiology and diagnostics of carbapenem resistance in Gram-negative bacteria. Clin Infect Dis 69(Suppl 7):S521\u2013S528. https:\/\/doi.org\/10.1093\/cid\/ciz824","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05704-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05704-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05704-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:11:21Z","timestamp":1792559481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05704-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":32,"alternative-id":["5704"],"URL":"https:\/\/doi.org\/10.1007\/s10096-026-05704-0","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"25 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The hospital cohort was a retrospective secondary analysis of data collected under a protocol approved by the Ethics Committee of Nanjing Drum Tower Hospital (approval no. 2025\u20110443\u201102). The requirement for informed consent was waived. The MIMIC-IV database contains de-identified data. The Institutional Review Board of Beth Israel Deaconess Medical Center approved the sharing of the MIMIC-IV research resource and granted a waiver of informed consent. Access to the database was granted after completion of the required training and approval as a credentialed user (certification no. 52712098). Access to and use of the MIMIC-IV database complied with the PhysioNet data-use agreement.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for informed consent was waived for the retrospective hospital cohort. The MIMIC-IV research resource contains de-identified data, and the relevant institutional review board granted a waiver of informed consent.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}